Abstract
The single-strand conformation polymorphism (SSCP) procedure has been applied in routine testing for hereditary diseases. Temperature, running buffer, gel composition, and fragment length can influence its sensitivity. Mutation detection in the clinical setting depends on the development of automated technology, especially for large genes, such as the dihydropyrimidine dehydrogenase (DPYD) gene, which codes the initial, rate-limiting enzyme in the catabolism of 5-fluorouracil (5FU). The authors have optimized the condition of SSCP with an automated system (GenePhor system, GE Healthcare UK Ltd.) to screen genetic polymorphisms in the DPYD gene. The efficiency of the method was evaluated using 21 positive controls (DNA samples with polymorphisms in the DPYD gene, previously characterized) and DNA samples from 35 Japanese. Results showed that the use of three different running buffers (pH 7.4, 8.3, and 9.0) in combination with other optimized conditions (10% polyacrylamide gel, 60–90 min at constant 900 V at 5°C) resulted in a high polymorphism detection rate (95.3%), which was considered appropriate for routine screening. Therefore, this strategy could be useful for pharmacogenetic studies on 5FU.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Antonarakis SE (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.Hum Mutat 11:1–3
Custodio N, Carmo-Fonseca M (2001) Quality control of gene expression in the nucleus. J Cell Mol Med 5:267–275
Diasio RB, Beavers TL, Carpenter JT (1988) Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J Clin Invest 81:47–51
Ezzeldin H, Okamoto Y, Johnson MR, Diasio RB (2002) A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency. Anal Biochem 306:63–73
Ezzeldin H, Johnson MR, Okamoto Y, Diasio R (2003) Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity. Clin Cancer Res 9:3021–3028
Fleming RA, Milano G, Thyss A, Etienne MC, Renee N, Schneider M, Demard F (1992) Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res 52:2899–2902
Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2:404–414
Hayashi K, Yandell DW (1993) How sensitive is PCR-SSCP? Hum Mutat 2:338–346
Jaeckel S, Epplen JT, Kauth M, Miterski B, Tschentscher F, Epplen C (1998) Polymerase chain reaction-single strand conformation polymorphism or how to detect reliably and efficiently each sequence variation in many samples and many genes. Electrophoresis 19:3055–3061
Johnson MR, Wang K, Tillmanns S, Albin N, Diasio RB (1997) Structural organization of the human dihydropyrimidine dehydrogenase gene. Cancer Res 57:1660–1663
Jorge SB, Melo MB, Costa FF, Sonati MF (2003) Screening for mutations in human alpha-globin genes by nonradioactive single-strand conformation polymorphism. Braz J Med Biol Res 36:1471–1474
Kukita Y, Tahira T, Sommer SS, Hayashi K (1997) SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10:400–407
Kwok PY, Chen X (2003) Detection of single nucleotide polymorphisms. Curr Issues Mol Biol 5:43–60
Mattison LK, Johnson MR, Diasio RB (2002) A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms. Pharmacogenetics 12:133–144
McLeod HL, Collie-Duguid ES, Vreken P, Johnson MR, Wei X, Sapone A, Diasio RB, Fernandez-Salguero P, van Kuilenberg AB, van Gennip AH, Gonzalez FJ (1998) Nomenclature for human DPYD alleles. Pharmacogenetics 8:455–459
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879
Ridge SA, Sludden J, Brown O, Robertson L, Wei X, Sapone A, Fernandez-Salguero PM, Gonzalez FJ, Vreken P, van Kuilenburg AB, van Gennip AH, McLeod HL (1998) Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects. Br J Clin Pharmacol 46:151–156
Salazar LA, Hirata MH, Hirata RD (2002) Increasing the sensitivity of single-strand conformation polymorphism analysis of the LDLR gene mutations in Brazilian patients with familial hypercholesterolemia. Clin Chem Lab Med 40:441–445
Wei X, Elizondo G, Sapone A, McLeod HL, Raunio H, Fernandez-Salguero P, Gonzalez FJ (1998) Characterization of the human dihydropyrimidine dehydrogenase gene. Genomics 51:391–400
Yamaguchi K, Arai Y, Kanda Y, Akagi K (2001) Germline mutation of dihydropyrimidine dehydrogenase gene among a Japanese population in relation to toxicity to 5-Fluorouracil. Jpn J Cancer Res 92:337–342
Acknowledgments
This work was supported in part by a Grant-in-Aid for Young Scientists (B) (no. 16790311) from the Ministry of Education, Science, Sports, and Culture, Japan, a Grant-in Aid from the Japan Research Foundation for Clinical Pharmacology, and a Grant-in-Aid from the Aichi Cancer Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okamoto, Y., Ueta, A., Sumi, S. et al. SSCP Screening of the Dihydropyrimidine Dehydrogenase Gene Polymorphisms of the Japanese Population Using a Semi-automated Electrophoresis Unit. Biochem Genet 45, 713–724 (2007). https://doi.org/10.1007/s10528-007-9109-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-007-9109-7